11 research outputs found

    Oxidation and Release of Ruthenium from White Inclusions

    Get PDF
    In this paper the laboratory test results on oxidation and release of ruthenium as a fission product element are summarised. The ruthenium appears in the nuclear fuel pellets of pressurized water reactors as one of the fission product elements during burnup. In case of severe accident when the air can contact the degraded hot fuel, the ruthenium oxidises and its gaseous oxides, especially the RuO4, release rapidly from the pellets to the environment. Because of high radio- and chemotoxicity of ruthenium tetra-oxide further experimental study of oxidation and release is essential. It is well known that ruthenium in the irradiated fuel UO2 fuel appears in small metallic alloy precipitations together with fission product elements as Mo, Rh, Pd and Tc. The precipitations are seen in the metallographic pictures as white inclusions. This separate effect study focused on the differences in the release rate of gaseous ruthenium oxides when pure ruthenium or Mo-Ru-Rh-Pd metallic alloy is present in the simulated nuclear fuel. The oxidation and release were studied at constant reaction temperatures of 1000 or 1100 Celsius. The tests showed that during high-temperature oxidation of the Mo-Ru-Rh-Pd alloy in air flow the release rate of gaseous ruthenium oxides is reduced to 60-80% compared to the value measured in case of oxidation of pure metallic ruthenium powder in the same thermal-hydraulic conditions. Furthermore, if additional elements and chemical compounds representing other fission products were added in the alloy, a time delay of 30 to 60 min appeared in the release of gaseous ruthenium to the room-temperature environment. One of the main results was that in the outlet air flow reaching the environment the partial pressure of RuO4 was far above what could be expected for room-temperature equilibrium conditions. It was pointed out that the highly volatile RuO4 can decompose in solid, non-volatile RuO2 and O2. The X-ray fluorescence analysis results showed that some ruthenium compounds deposited on the colder circuit walls of the test facility. This suggests RuO4 is not fully airstable, i.e., its stability in air can be limited in time.JRC.F.4-Nuclear design safet

    Oxidation and Release of Ruthenium from Short Fuel Rods above 1500oC

    Get PDF
    The fission product ruthenium is radiotoxic and in oxidized form as ruthenium-tetroxide (RuO4) also chemical toxic. During fuel element change or in case of a leakage in fuel storages, air flows in the containment or fuel storage. If the circulation pump fails, the fuel elements are heated-up, and at high temperatures gaseous ruthenium oxides are formed and rapidly released from the fuel. Due to the significant higher volatility of RuO4 in the Chernobyl Catastrophe the measured concentration of the Ru-isotopes in the fall-outs was comparable to those of iodine and caesium. In order to get more insight in the chemical and physical behaviour of this fission product under severe accident conditions, the Ruthenium release was studied in a series of Separate Effect Tests (RUSET). In the test short fuel rod segments were used and exposed to air and steam atmosphere at high temperatures. The experiments in air atmosphere showed, that the partial pressures of the released Ru-oxides was two orders of magnitudes lower compared to those measured in previous tests with Ru-powder diluted in a ZrO2 matrix. It was found that ruthenium was not released in steam atmosphere in the examined temperature range. Furthermore, the temperature dependence of the deposition was detected by XRF analysis.JRC.F.4-Nuclear design safet

    Experimental investigation of the late phase of spent fuel pool accidents

    Get PDF
    Experimental programmes have been carried out in order to investigate the behaviour of nuclear fuel components in high-temperature air atmosphere, which characterises the main conditions of the late phase of spent fuel pool accidents. The tests provided new data on the oxidation of zirconium cladding in different atmospheres, on the oxidation and release of ruthenium from fuel pellets and on the integral behaviour of fuel bundles. The integral test confirmed that water injection into the spent fuel storage pool is the right measure to terminate a severe accident

    Aldosterone Antagonists in Monotherapy Are Protective against Streptozotocin-Induced Diabetic Nephropathy in Rats

    Get PDF
    Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) are the standard clinical therapy of diabetic nephropathy (DN), while aldosterone antagonists are only used as adjuncts. Previously in experimental DN we showed that Na/K ATPase (NKA) is mislocated and angiotensin II leads to superimposed renal progression. Here we investigated the monotherapeutic effect of aldosterone blockers on the progression of DN and renal NKA alteration in comparison to ACEi and ARBs. Streptozotocin-diabetic rats developing DN were treated with aldosterone antagonists; ACEi and ARB. Renal function, morphology, protein level and tubular localization of NKA were analyzed. To evaluate the effect of high glucose per se; HK-2 proximal tubular cells were cultured in normal or high concentration of glucose and treated with the same agents. Aldosterone antagonists were the most effective in ameliorating functional and structural kidney damage and they normalized diabetes induced bradycardia and weight loss. Aldosterone blockers also prevented hyperglycemia and diabetes induced increase in NKA protein level and enzyme mislocation. A monotherapy with aldosterone antagonists might be as, or more effective than ACEi or ARBs in the prevention of STZ-induced DN. Furthermore the alteration of the NKA could represent a novel pathophysiological feature of DN and might serve as an additional target of aldosterone blockers

    Effect of temperature on the development time and survival of preimaginal Culex hepperi (Diptera: Culicidae)

    No full text
    The aim of this research was to evaluate the effect of temperature on the development time and survival of Culex (Culex) hepperi Casal and García, 1967. Individuals were reared in the laboratory, from the first larval stage to adult emergence, at five constant temperatures: 15, 20, 25, 30, and 33°C. The total development time was inversely related to temperature between 15 and 25°C. No differences were observed in the development time between sexes and no adults emerged at 33°C. In the larval stages III and IV, the time required for molting to the next stage increased at 30°C. The highest survival was recorded at 20°C. The more developed stages were less resistant to temperatures above and below 20°C. According to the nonlinear model of Briére, the lower and upper development thresholds were 2.6 and 33°C, respectively. Our results suggest that the effect of temperature depends upon the stage of development of C. hepperi.<br>El objetivo de este trabajo fue analizar el efecto de la temperatura sobre el tiempo de desarrollo y la supervivencia preimaginal de Culex (Culex) hepperi Casal y García, 1967. Los individuos fueron criados en laboratorio, desde el primer estadio larval hasta la emergencia del adulto, a cinco temperaturas constantes: 15, 20, 25, 30 y 33°C. El tiempo total de desarrollo se relacionó de manera inversa con la temperatura entre 15 y 25°C. No se detectaron diferencias entre sexos en el tiempo de desarrollo y ningún individuo alcanzó el estado adulto a 33°C. En los estadios larvales III y IV, el tiempo requerido para mudar al siguiente estadio fue mayor a 30°C. La supervivencia más alta se registró a 20°C. Los estadios más avanzados fueron menos resistentes a las temperaturas por encima y por debajo de los 20°C. De acuerdo con el modelo no lineal de Briére, los umbrales de desarrollo inferior y superior fueron 2.6 y 33°C, respectivamente. Nuestros resultados sugieren que el efecto de la temperatura depende del estadio de desarrollo de C. hepperi

    Western blot analysis of Na/K ATPase (NKA).

    No full text
    <p>Aldosterone antagonists were the most effective in decreasing diabetes and hyperglycemia induced elevation of tubular NKA protein level. Top panel: Representative examples of Western blot analysis. Lower panels: <i>A</i>: Densitometric analysis of NKA protein levels in kidney homogenates of control, diabetic and treated diabetic rats. <i>B</i>: Densitometric analysis of NKA protein levels in HK-2 tubular cells. Bar graph represents densitometric analysis from multiple experiments. Data represent means ± SD; *p<0.05 <i>vs</i> Control; §p<0.05 <i>vs</i> Diabetes, respectively; (bars show means±SD; n = 8–10/group). IOD – integrated optical density.</p

    Confocal images of control, diabetic and treated diabetic rats.

    No full text
    <p>Aldosterone inhibitors prevented the mislocation of NKA induced by diabetes in proximal tubules. Representative pictures of immunofluorescence staining of kidney sections for Na/K ATPase (NKA, green) in control (A), streptozotocin-diabetic (B) and diabetic, Enalapril (C), Losartan (D), Spironolactone (E) and Eplerenone (F) treated rats (63x magnification; scale bar–10 μm). Nuclei are stained blue with Hoechst. PT-proximal tubule, DT-distal tubule, Bm-basal membrane, Lu – apical membrane at the lumen and Nucl – nuclei. Fluorescent signal intensity of NKA (green) generated from a line shown as red arrow in the merged image are shown on the bottom right of each panel.</p

    Metabolic and renal parameters of control, diabetic and treated diabetic rats.

    No full text
    <p>Data are means ± SD, n = 8–10/group, <sup>*</sup>p<0.05 vs. C; <sup>§</sup>p<0.05 vs. D, <sup>**</sup>p<0.01 vs. C; <sup>§§</sup>p<0.01 vs. D, <sup>***</sup>p<0.001 vs. C; <sup>§§§</sup>p<0.001 vs. D; respectively. UD–undetectable.</p

    Renal histopathology in control, diabetic and treated diabetic rats.

    No full text
    <p>Aldosterone antagonists were the most effective in attenuating the structural lesions of DN. Representative PAS staining of kidney sections (40x magnification; scale bar –50 μm): non-diabetic control (A), STZ-induced diabetic (B), Enalapril (E), Losartan (F), Spironolactone (G) and Eplerenone (H) treated diabetic rats (n = 8–10/group). Long, wide headed arrows point on mesangial matrix; long, narrow headed arrows on arterioles. Armanni-Ebstein lesions are marked with short, wide headed arrows. <i>C</i>: Mesangial fractional volume values (Vv) are defined by the ratio of mesangial area/glomerular tuft area. The mesangial area is determined by assessment of PAS-positive and nucleus-free areas in the mesangium. *p<0.05 <i>vs</i> Control; §p<0.05 <i>vs</i> Diabetes, respectively; (bars show means ± SD). <i>D</i>: Arteriolar hyalinosis is defined by the average of hyalinized quarters of arterioles. The hyalin is determined by assessment of PAS-positive and nucleus-free areas within the arterioles. *p<0.05 <i>vs</i> Control; §p<0.05 <i>vs</i> Diabetes, respectively; (bars show means ± SD).</p
    corecore